Early Heart Check After CAR-T Cell Treatment
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy, Injuries & trauma clinical trials.
This study checks your heart function early after CAR-T cell cancer treatment. It uses a quick heart ultrasound to look for changes soon after the infusion.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You received CAR-T cell treatment 3 to 5 days ago
- You had a heart ultrasound and EKG before starting CAR-T therapy
- You are okay with being in the study
- You have health insurance (social security or state medical help)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a CAR-T cell therapy is safe and effective for people with relapsed or refractory lymphoma, leukemia, or myeloma whose tumors have the right target markers. You may qualify if your health (heart, lungs, kidneys, liver) and blood counts are within required limits.
This trial tests a new CAR-T cell therapy for people with certain blood cancers (B-cell acute lymphoblastic leukemia, B-cell lymphoma, or multiple myeloma) that have come back or stopped responding to treatment. The therapy uses your own immune cells, modified in a lab to attack cancer cells, then given back to you intravenously.
This study looks at how the standard chemotherapy given before CAR T-cell therapy affects the treatment's success in people with large B-cell lymphoma that has come back or not responded to previous treatment. It may help doctors find the best way to prepare your body for CAR T-cells.
This trial adds a low dose of radiation to the entire body before CAR T cell therapy for patients with acute lymphoblastic leukemia. The goal is to see if this extra step helps the CAR T cells work better, without adding much extra discomfort.
This study tests a personalized cell treatment called CAR-T for people whose blood cancer (like lymphoma, leukemia, or chronic lymphocytic leukemia) has come back or not gotten better after standard treatment. The therapy uses your own immune cells, modified in a lab, to find and fight the cancer.
This study looks at how CAR-T therapy affects blood cell counts (cytopenia) in people with multiple myeloma or certain lymphomas/leukemias. You will provide biological samples to help researchers understand these effects.
Hear when a new CAR T Cell trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.